Peptide Protocol IQ
Catalogue entry — evidence review not completed

hGH Fragment 176-191

The 176-191 fragment of human growth hormone, the same sequence marketed as AOD-9604.

Molecule class
Growth hormone C-terminal fragment
Category
Metabolic
Market prevalence
5 of 9 catalogues

What this page does not tell you

No evidence review has been completed for hGH Fragment 176-191. This page therefore contains no evidence grade, no claim about what it does, no quantity, no duration, and no interaction assessment. The description above states what the molecule is, not what it has been shown to do. Its presence in this catalogue is a record that other sites list it, and is not a statement about it in either direction.

Market presence

Listed on 5 of 9 reference catalogues

How widely a compound is sold and written about. This measures commercial distribution, not scientific support, and the two frequently diverge.

  • peptidedosingprotocols.comdoes not list this compound
  • lotilabs.comlists this compound
  • purehealthpeptides.comlists this compound
  • bluewavecompounds.comdoes not list this compound
  • corepeptidesdirect.comdoes not list this compound
  • peptidescalculator.comlists this compound
  • thepeptidealmanac.comlists this compound
  • pathtopeptides.comdoes not list this compound
  • peptideprotocolportal.comlists this compound

Next step

Go to the primary literature yourself

Rather than summarise research we have not yet reviewed, we send you to the source. When reading what you find, the questions that matter most are whether any of it is human evidence, how large and how long the studies were, and whether the route studied matches the route being sold.

Same category

Other Metabolic compounds in the catalogue